Putative role of prostaglandin receptor in intracerebral hemorrhage

Frontiers in Neurology

Volumn OCT, Issue , 2012, Pages

  Mohan, Shekher ^a   Ahmad, Abdullah S ^a   Glushakov, Alexander V ^a   Chambers, Chase ^a   Doré, Sylvain ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; GPCR; Inflammation; Neurodegenerative diseases; Stroke; Therapy

Indexed keywords

EID: 84870653045     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00145     Document Type: Article

References (273)

1. Abe, T., Kunz,A.,Shimamura,M.,Zhou, P., Anrather, J., and Iadecola, C. (2009). The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J. Cereb. Blood Flow Metab. 29, 66-72.
2. Abramovitz, M., Boie, Y., Nguyen, T., Rushmore, T. H., Bayne, M. A., Metters, K. M., et al. (1994). Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269, 2632-2636.
3. Adeoye, O., and Broderick, J. P. (2010). Advances in the management of intracerebral hemorrhage. Nat. Rev. Neurol. 6, 593-601.
4. Ahmad, A. S., Ahmad, M., De Brum-Fernandes,A.J., and Doré, S. (2005). Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res. 1066, 71-77.
5. Ahmad, A. S., Ahmad, M., Maruyama, T., Narumiya, S., and Doré, S. (2010a). Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice. Age (Dordr.) 32, 271-282.
6. Ahmad, M., Saleem, S., Shah, Z., Maruyama, T., Narumiya, S., and Doré, S. (2010b). The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke. Exp. Transl. Stroke Med. 2, 12.
7. Ahmad, A. S., Kim, Y. T., Ahmad, M., Maruyama, T., and Doré, S. (2008). Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. Neurotox. Res. 14, 343-351.
8. Ahmad, A. S., Saleem, S., Ahmad, M., and Doré, S. (2006a). Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol. Sci. 89,265-270.
9. Ahmad, A. S., Zhuang, H., Echeverria, V., and Doré, S. (2006b). Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity. J. Neurotrauma 23, 1895-1903.
10. Ahmad, M., Ahmad, A. S., Zhuang, H., Maruyama, T., Narumiya, S., and Doré, S. (2007). Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury. J. Neuroimmunol. 184, 172-179.
11. Anderson, C. S., Huang, Y., Arima, H., Heeley, E., Skulina, C., Parsons, M. W., et al. (2010). Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 41, 307-312.
12. Angeli, V., Staumont, D., Charbonnier, A. S., Hammad, H., Gosset, P., Pichavant, M., et al. (2004). Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172, 3822-3829.
13. Anrather, J., Gallo, E. F., Kawano, T., Orio, M., Abe, T., Gooden, C., et al. (2011). Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury. PLoS ONE 6, e25916. doi:10.1371/journal.pone.0025916
14. Ansar, S., Larsen, C., Maddahi, A., andEdvinsson, L. (2010).Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries. Brain Res. 1316, 163-172.
15. Araki, H., Ukawa, H., Sugawa, Y., Yagi, K., Suzuki, K., and Takeuchi, K. (2000). The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach. Aliment. Pharmacol Ther. 14(Suppl 1), 116-124.
16. Ayer, R., Jadhav, V., Sugawara, T., and Zhang, J. H. (2011). The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage. Acta Neurochir. Suppl. 111, 145-149.
17. Ba, F., Giuliani, F., Camicioli, R., and Saqqur, M. (2012). A reversible cerebral vasoconstriction syndrome. BMJ Case Rep.
18. Bastepe, M., and Ashby, B. (1999). Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor. Br. J. Pharmacol. 126, 365-371.
19. Batshake, B., Nilsson, C., and Sundelin, J. (1995). Molecular characterization of the mouse prostanoid EP1 receptor gene. Eur. J. Biochem. 231, 809-814.
20. Bentzer, P., and Grande, P. O. (2004). Low-dose prostacyclin restores an increased protein permeability after trauma in cat skeletal muscle. J. Trauma 56, 385-392.
21. Berges, S., Moulin, T., Berger, E., Tatu, L., Sablot, D., Challier, B., et al. (2000). Seizures and epilepsy following strokes: recurrence factors. Eur. Neurol. 43, 3-8.
22. Borg, C., Lim, C. T., Yeomans, D. C., Dieter, J. P., Komiotis, D., Anderson, E. G., et al. (1994). Purification of rat brain, rabbit aorta, and human platelet thromboxane A2/prostaglandin H2 receptors by immunoaffinity chromatography employing antipeptide and antireceptor antibodies. J. Biol. Chem. 269, 6109-6116.
23. Bousser, M. G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K. M., et al. (2011). Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet 377, 2013-2022.
24. Burn, J., Dennis, M., Bamford, J., Sandercock, P., Wade, D., and Warlow, C. (1997). Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 315, 1582-1587.
25. Caggiano,A. O., and Kraig, R. P. (1999). Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72, 565-575.
26. Carlson, N. G., Rojas, M. A., Black, J. D., Redd, J. W., Hille, J., Hill, K. E., et al. (2009). Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. J. Neuroinflammation 6, 5.
27. Casteleijn, E., Kuiper, J., van Rooij, H. C., Kamps, J. A., Koster, J. F., and van Berkel, T. J. (1988). Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. Biochem. J. 250, 77-80.
28. Cazevieille, C., Muller, A., and Bonne, C (1993). Prostacyclin (PGI2) pro tects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury. Neurosci. Lett. 160, 106-108.
29. Cazevieille, C., Muller, A., Meynier, F., Dutrait, N., and Bonne, C. (1994). Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24, 395-398.
30. Chamorro, A. (2009). TP receptor antagonism: a new concept in atherothrombosis and stroke prevention. Cerebrovasc. Dis. 27(Suppl 3), 20-27.
31. Chaudhry, U., Zhuang, H., Crain, B. J., and Doré, S. (2008). Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease. Alzheimers Dement. 4, 6-13.
32. Chaudhry, U., Zhuang, H., and Doré, S. (2010). Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease. Exp. Neurol. 223, 359-365.
33. Chemtob, S., Beharry, K., Rex, J., Varma, D R., and Aranda, J. V. (1990). Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 21, 777-784.
34. Cheung, U., Atwood, H. L., and Zucker, R. S. (2006). Presynaptic effectors contributing to cAMP-induced synaptic potentiation in Drosophila. J. Neurobiol. 66, 273-280.
35. Choi, J. S., Kim, H. Y., Chun, M. H., Chung, J. W., and Lee, M. Y. (2006). Expression of prostaglandin E2 receptor subtypes, EP2 and EP4, in the rat hippocampus after cerebral ischemia and ischemic tolerance. Cell Tissue Res. 324, 203-211.
36. Choi, S. Y., Choi, B. H., Suh, B. C., Chae, H. D., Kim, J. S., Shin, M. J., et al. (2001). Potentiation of PGE(2)-mediated cAMP production during neuronal differentiation of human neuroblastoma SK-N-BE(2)C cells. J. Neurochem. 79, 303-310.
37. Christensen, A. E., Selheim, F., de Rooij, J., Dremier, S., Schwede, F., Dao, K. K., et al. (2003). cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394-35402.
38. Colman, R. W. (1991). Receptors that activate platelets. Proc. Soc. Exp. Biol. Med. 197, 242-248.
39. Cui, Y., Takamatsu, H., Kakiuchi, T., Ohba, H., Kataoka, Y., Yokoyama, C., et al. (2006). Neuroprotection by a central nervous system-type prostacyclin receptor ligand demonstrated in monkeys subjected to middle cerebral artery occlusion and reperfusion: a positron emission tomography study. Stroke 37, 2830-2836.
40. Darius, H., Michael-Hepp, J., Thierauch, K. H., and Fisch, A. (1994). Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. Eur. J. Pharmacol. 258, 207-213.
41. De Clerck, F., and Janssen, P. A. (1990). 5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease. Blood Coagul. Fibrinolysis 1, 201-209.
42. De Herdt, V., Dumont, F., Henon, H., Derambure, P., Vonck, K., Leys, D., et al. (2011). Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 77, 1794-1800.
43. De Reuck, J. L. (2007). Stroke-related seizures and epilepsy. Neurol. Neurochir. Pol. 41, 144-149.
44. de Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A., et al. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396, 474-477.
45. Desai, S., April, H., Nwaneshiudu, C., and Ashby, B. (2000). Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol. Pharmacol. 58, 1279-1286.
46. Doré, S., Sampei, K., Goto, S., Alkayed, N. J., Guastella, D., Blackshaw, S., et al. (1999). Heme oxygenase-2 is neu-roprotective in cerebral ischemia. Mol. Med. 5, 656-663.
47. Dumont, I., Hou, X., Hardy, P., Peri, K. G., Beauchamp, M., Najarian, T., et al. (1999). Developmental regulation of endothelial nitric oxide synthase in cerebral vessels of newborn pig by prostaglandin E(2). J. Pharmacol. Exp. Ther. 291, 627-633.
48. Echeverria, V., Clerman, A., and Doré, S. (2005). Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure. Eur. J. Neurosci. 22, 2199-2206.
49. Eguchi, N., Minami, T., Shirafuji, N., Kanaoka, Y., Tanaka, T., Nagata, A., et al. (1999). Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 96, 726-730.
50. Ek, M., Arias, C., Sawchenko, P., and Ericsson-Dahlstrand, A. (2000). Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J. Comp. Neurol. 428, 5-20.
51. Falcetti, E., Hall, S. M., Phillips, P. G., Patel, J., Morrell, N. W., Haworth, S. G., et al. (2010). Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idio-pathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 182, 1161-1170.
52. Fang, Y. C., Wu, J. S., Chen, J. J., Cheung, W. M., Tseng, P. H., Tam, K. B., et al. (2006). Induction of prostacyclin/PGI2 synthase expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 26, 491-501.
53. Fernandes, H. M., Gregson, B., Siddique, S., and Mendelow, A. D. (2000). Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 31, 2511-2516.
54. Fiebich, B. L., Schleicher, S., Spleiss, O., Czygan, M., and Hull, M. (2001). Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 79, 950-958.
55. Fischborn, S. V., Soerensen, J., and Potschka, H. (2010). Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling mo del in mice. Epilepsy Res. 91, 57-65.
56. Font-Nieves, M., Sans-Fons, M. G., Gorina, R., Bonfill-Teixidor, E., Salas-Perdomo, A., Marquez-Kisinousky, L., et al. (2012). Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes.J. Biol Chem. 287, 6454-6468.
57. Fujino, H., and Regan, J. W. (2006). EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol. Pharmacol. 69, 5-10.
58. Fujino, H., Salvi, S., and Regan, J. W. (2005). Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol. Pharmacol. 68, 251-259.
59. Fujino, H., West, K. A., and Regan, J. W. (2002). Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277, 2614-2619.
60. Fujino, H., Xu, W., and Regan, J. W. (2003). Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 278, 12151-12156.
61. Fukuhara, S., Sakurai, A.,Sano, H., Yamagishi, A., Somekawa, S., Takakura, N., et al. (2005). Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25, 136-146.
62. Gardenfors, F., Nilsson, A., Ungerstedt, U., and Nordstrom, C. H. (2004). Adverse biochemical and physiological effects of prostacyclin in experimental brain oedema. Acta Anaes-thesiol. Scand. 48, 1316-1321.
63. Gautier, S., Ouk, T., Petrault, O., Caron, J., and Bordet, R. (2009). Neu-trophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br. J. Pharmacol. 156, 673-679.
64. Gekel, I., and Neher, E. (2008). Application of an Epac activator enhances neurotransmitter release at excitatory central synapses. J. Neurosci. 28, 7991-8002.
65. Gelir, E., Arslan, S. O., Sayan, H., and Pinar, L. (2005). Effect of rapid-eye-movement sleep deprivation on rat hypothalamic prostaglandins. Prostaglandins Leukot. Essent. Fatty Acids 73, 391-396.
66. Gelosa, P., Ballerio, R., Banfi, C., Nobili, E., Gianella, A., Pignieri, A., et al. (2010). Terutroban, a throm-boxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin. J. Pharmacol. Exp. Ther. 334, 199-205.
67. Gendron, T. F., Brunette, E., Tauskela, J. S., and Morley, P. (2005). The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection. Eur. J. Pharmacol. 517, 17-27.
68. Genovese, T., Esposito, E., Maz-zon, E., Di Paola, R., Muia, C., Meli, R., et al. (2008). Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. Shock 30, 142-152.
69. Gerlo, S., Verdood, P., and Kooijman, R. (2010). Modulation of cytokine production by cyclic adenosine monophosphate analogs in human leukocytes.J. Interferon Cytokine Res. 30, 883-891.
70. Goldstein, L. B., and Simel, D. L. (2005). Is this patient having a stroke? JAMA 293, 2391-2402.
71. Gong, C., Boulis, N., Qian, J., Turner, D. E., Hoff, J. T., and Keep, R. F. (2001). Intracerebral hemorrhage-induced neuronal death. Neurosurgery 48, 875-882; discussion 882-873.
72. Gotoh, M., Kitanaka, J., Hirasawa, Y., Kondo, K., and Baba, A. (1994). Desensitization of prostaglandin F2 alpha receptor-mediated phospho-inositide hydrolysis in cultured rat astrocytes. Neurochem. Res. 19, 679-685.
73. Grill, M., Heinemann, A., Hoefler, G., Peskar, B. A., and Schuligoi, R. (2008). Effect of endotoxin treatment on the expression and localization of spinal cyclooxyge-nase, prostaglandin synthases, and PGD2 receptors. J. Neurochem. 104, 1345-1357.
74. Hammad, H., De Heer, H. J., Soul-lie, T., Hoogsteden, H. C., Trot-tein, F., and Lambrecht, B. N. (2003). Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J. Immunol. 171, 3936-3940.
75. Hao, C. M., and Breyer, M. D. (2007). Physiologic and pathophysiologic roles of lipid mediators in the kidney. KidneyInt.71, 1105-1115.
76. Hasegawa, H., Negishi, M., and Ichikawa, A. (1996). Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J Biol. Chem. 271, 1857-1860.
77. Hata, A. N., and Breyer, R. M. (2004). Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103, 147-166.
78. Hatoum, O. A., Gauthier, K. M., Binion, D. G., Miura, H., Telford, G., Otter-son, M. F., et al. (2005). Novel mechanism of vasodilation in inflammatory bowel disease. Arterioscler. Thromb. Vasc. Biol. 25, 2355-2361.
79. Hayaishi, O. (2002). Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D2 system. J Appl. Physiol. 92, 863-868.
80. Heaslip, R. J., and Sickels, B. D. (1989). Evidence that prostaglandins can contract the rat aorta via a novel protein kinase C-dependent mechanism. J. Pharmacol. Exp. Ther. 250, 44-51.
81. Hebert, R. L., O'Connor, T., Neville, C., Burns, K. D., Laneuville, O., and Peterson, L. N. (1998). Prostanoid signaling, localization, and expression of IP receptors in rat thick ascending limb cells. Am. J. Physiol. 275, F904-F914.
82. Heo, J. H., Lucero, J., Abumiya, T., Koziol, J. A., Copeland, B. R., and Del Zoppo, G. J. (1999). Matrix met-alloproteinases increase very early during experimental focal cerebral ischemia.J. Cereb. Blood Flow Metab. 19, 624-633.
83. Hickenbottom, S. L., Grotta, J. C., Strong, R., Denner, L. A., and Aronowski,J. (1999). Nuclear factor-kappaB and cell death after experimental intracerebral hemorrhage in rats. Stroke 30, 2472-2477; discussion 2477-2478.
84. Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., et al. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193, 255-261.
85. Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., etal. (1991). Cloning and expression of cDNA for a human throm-boxane A2 receptor. Nature 349, 617-620.
86. Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., and Narumiya, S. (1994a). Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. U.S.A. 91, 11192-11196.
87. Hirata, T., Kakizuka, A., Ushikubi, F., Fuse, I., Okuma, M., and Narumiya, S. (1994b). Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J. Clin. Invest. 94, 1662-1667.
88. Hirata, T., Ushikubi, F., Kakizuka, A., Okuma, M., and Narumiya, S. (1996). Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J. Clin. Invest. 97, 949-956.
89. Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., et al. (1993). Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268, 7759-7762.
90. Honma, S., Saika, M., Ohkubo, S., Kurose, H., and Nakahata, N. (2006). Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. Eur. J. Pharmacol. 545, 100-108.
91. Hsu, K. S., Huang, C. C., Kan, W. M., and Gean, P. W. (1996). TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocam-pal CA1 neurons. Am. J. Physiol. 271, C1269-C1277.
92. Hsu, K. S., and Kan, W. M. (1996). Thromboxane A2 agonist modulation of excitatory synaptic transmission in the rat hippocampal slice. Br. J. Pharmacol. 118, 2220-2227.
93. Hua, Y., Xi, G., Keep, R. F., and Hoff, J. T. (2000). Complement activation in the brain after experimental intracerebral hemorrhage. J. Neuro-surg. 92, 1016-1022.
94. Huang, E P., Xi, G., Keep, R. F., Hua, Y., Nemoianu, A., and Hoff, J. T. (2002). Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 96, 287-293.
95. Ikeda-Matsuo, Y., Tanji, H., Narumiya, S., and Sasaki, Y (2011). Inhibition of prostaglandin E2 EP3 receptors improves stroke injury via anti-inflammatory and anti-apoptotic mechanisms. J. Neuroim-munol. 238, 34-43.
96. Ikeda-Matsuo, Y., Tanji, H., Ota, A., Hirayama, Y., Uematsu, S., Akira, S., et al. (2010). Microso-mal prostaglandin E synthase-1 contributes to ischaemic excitotoxic-ity through prostaglandin E2 EP3 receptors. Br. J. Pharmacol. 160, 847-859.
97. Irie, A., Sugimoto, Y., Namba, T., Asano, T., Ichikawa, A., and Negishi, M. (1994). The C-terminus of the prostaglandin-E-receptor EP3 subtype is essential for activation of GTP-binding protein. Eur. J. Biochem. 224, 161-166.
98. Irie, A., Sugimoto, Y., Namba, T., Hara-zono, A., Honda, A., Watabe, A., et al. (1993). Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem. 217, 313-318.
99. Ishikawa, T. O., Tamai, Y., Rochelle, J. M., Hirata, M., Namba, T., Sugimoto, Y., et al. (1996). Mapping of the genes encoding mouse prostaglandin D, E, and F and prostacyclin receptors. Genomics 32, 285-288.
100. Ito, S., Narumiya, S., and Hayaishi, O. (1989). Prostaglandin D2: a biochemical perspective. Prostaglandins Leukot. Essent. Fatty Acids 37, 219-234.
101. Jiang, J., Ganesh, T., Du, Y., Quan, Y., Serrano, G., Qui, M., et al. (2012). Small molecule antagonist reveals seizure-induced mediation of neu-ronal injury by prostaglandin E2 receptor subtype EP2. Proc. Natl. Acad. Sci. U.S.A. 109, 3149-3154.
102. Jiang, J., Ganesh, T., Du, Y., Thepcha-tri, P., Rojas, A., Lewis, I., et al. (2010). Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc. Natl. Acad. Sci. U.S.A. 107, 2307-2312.
103. Jovanovic, N., Pavlovic, M., Mircevski, V.,Du, Q.,andJovanovic,A. (2006). An unexpected negative inotropic effect of prostaglandin F2α in the rat heart. Prostaglandins Other Lipid Medial SO, 110-119.
104. Justicia, C., Panes, J., Sole, S., Cervera, A., Deulofeu, R., Chamorro, A., et al. (2003). Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlu-sion/reperfusion of the middle cerebral artery in rats. J. Cereb. Blood FlowMetab. 23, 1430-1440.
105. Jyoti, A., Sethi, P., and Sharma, D. (2009). Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epilep-togenesis. Epilepsy Behav. 14, 300-308.
106. Kandasamy, S. B., and Hunt, W. A. (1990). Arachidonic acid and prostaglandins enhance potassium-stimulated calcium influx into rat brain synaptosomes. Neuropharma-cology 29, 825-829.
107. Kaneko, M., and Takahashi, T. (2004). Presynaptic mechanism underlying cAMP-dependent synaptic potenti-ation. J. Neurosci. 24, 5202-5208.
108. Kang, G., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. L.,et al. (2003). Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. J. Biol. Chem. 278, 8279-8285.
109. Katsuyama, M., Nishigaki, N., Sugimoto, Y., Morimoto, K., Negishi, M., Narumiya, S., et al. (1995). The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett. 372, 151-156.
110. Katsuyama, M., Sugimoto, Y., Namba, T., Irie, A., Negishi, M., Narumiya, S., et al. (1994). Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett. 344, 74-78.
111. Kawano, T., Anrather, J., Zhou, P., Park, L., Wang, G., Frys, K. A., et al. (2006). Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 12, 225-229.
112. Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., et al. (1998). A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279.
113. Kiermayer, S., Biondi, R. M., Imig, J., Plotz, G., Haupenthal, J., Zeuzem, S., et al. (2005). Epac activation converts cAMP from a proliferative into a differentiation signal in PC 12 cells. Mol. Biol. Cell 16, 5639-5648.
114. Kikkawa, Y., Kameda, K., Hirano, M., Sasaki, T., and Hirano, K. (2010). Impaired feedback regulation of the receptor activity and the myofila-ment Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 30, 1637-1650.
115. Kim, H. J., Chung, J. I., Lee, S. H., Jung, Y S., Moon, C. H., and Baik, E. J. (2008). Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res. 1193, 153-161.
116. Kim, Y. T., Moon, S. K., Maruyama, T., Narumiya, S., and Doré, S. (2012). Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity. Neurobiol Dis. 48, 58-65.
117. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., and Narumiya, S. (1997). Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122, 217-224.
118. Kishimoto, K., Li, R. C., Zhang, J., Klaus, J. A., Kibler, K. K., Doré, S., et al. (2010). Cytosolic phos-pholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxida-tive stress and MAP kinase phos-phorylation after cerebral ischemia in mice. J. Neuroinflammation 7, 42.
119. Kitanaka, J., Hashimoto, H., Sugimoto, Y., Sawada, M., Negishi, M., Suzu-mura, A.,et al. (1995). cDNA cloning of a thromboxane A2 receptor from rat astrocytes. Biochim. Biophys. Acta 1265, 220-223.
120. Kitanaka, J., Hasimoto, H., Sugimoto, Y., Negishi, M., Aino, H., Gotoh, M., et al. (1994). Cloning and expression of a cDNA for rat prostaglandin F2α receptor. Prostaglandins 48, 31-41.
121. Kitanaka, J., Ishibashi, T., and Baba, A. (1993). Phloretin as an antagonist of prostaglandin F2 alpha receptor in cultured rat astrocytes. J. Neu-rochem. 60, 704-708.
122. Kitanaka, J., Onoe, H., and Baba, A. (1991). Astrocytes possess prostaglandin F2 alpha receptors coupled to phospholipase C. Biochem. Biophys. Res. Commun. 178, 946-952.
123. Kitanaka, J., Takuma, K., Kondo, K., and Baba, A. (1996). Prostanoid receptor-mediated calcium signaling in cultured rat astrocytes. Jpn. J. Pharmacol. 71, 85-87.
124. Knock, G. A., De Silva, A. S., Snetkov, V. A., Siow, R., Thomas, G. D., Shi-raishi, M., et al. (2005). Modulation of PGF2α-andhypoxia-induced contraction of rat intrapulmonary artery by p38 MAPK inhibition: a nitric oxide-dependent mechanism. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L1039-L1048.
125. Kobayashi, T., and Narumiya, S. (2002). Function of prostanoid receptors: studies on knockout mice. Prostaglandins Other Lipid Mediat. 68-69, 557-573.
126. Koch, K. A., Wessale, J. L., Moreland, R., Reinhart, G. A., and Cox, B. E (2005). Effects of BW245C, a prostaglandin DP receptor agonist, on systemic and regional haemo dynamics in the anaesthetized rat. Clin. Exp. Pharmacol. Physiol. 32, 931-935.
127. Koide, M., Nystoriak, M. A., Bray-den, J. E., and Wellman, G. C. (2011). Impact of subarachnoid hemorrhage on local and global calcium signaling in cerebral artery myocytes. Acta Neurochir. Suppl. 110, 145-150.
128. Kollmar, R., Staykov, D., Dorfler, A., Schellinger, P. D., Schwab, S., and Bardutzky, J. (2010). Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke 41, 1684-1689.
129. Kong, D. L., Prough, D. S., Whitley, J. M., Taylor, C., Vines, S., Deal, D. D., et al. (1991). Hemorrhage and intracranial hypertension in combination increase cerebral production of thromboxane A2. Crit. CareMed. 19, 532-538.
130. Konger, R. L., Brouxhon, S., Partillo, S., Vanbuskirk, J., and Pentland, A. P. (2005). The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes. Exp. Dermatol. 14, 914-922.
131. Konger, R. L., Malaviya, R., and Pent-land, A. P. (1998). Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim. Biophys. Acta 1401, 221-234.
132. Kostic, V. S., Djuricic, B. M., and Mrsulja, B. B. (1984). Cerebrospinal fluid prostaglandin F2 alpha in stroke patients: no relationship to the degree of neurological deficit. Eur.Neurol. 23, 291-295.
133. Kotani, M., Tanaka, I., Ogawa, Y., Sug-anami, T., Matsumoto, T., Muro, S., et al. (2000). Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. J. Clin. Endocrinol Metab. 85, 4315-4322.
134. Kotani, M., Tanaka, I., Ogawa, Y., Usui, T., Mori, K., Ichikawa, A., et al. (1995). Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol. Pharmacol. 48, 869-879.
135. Kotani, M., Tanaka, I., Ogawa, Y., Usui, T., Tamura, N., Mori, K., et al. (1997). Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics 40, 425-434.
136. Kozasa, T., Jiang, X., Hart, M. J., Stern-weis, P. M., Singer, W. D., Gilman, A. G.,et al. (1998). p115 RhoGEF, a GTPase activating protein for Gal-pha12 and Galpha13. Science 280, 2109-2111.
137. Lapchak, P. A., Chapman, D. F., and Zivin, J. A. (2000). Metal -loproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 31, 3034-3040.
138. Laugwitz, K. L., Allgeier, A., Offer-manns, S., Spicher, K., Van Sande, J., Dumont, J. E., et al. (1996). The human thyrotropin receptor: a hep-tahelical receptor capable of stimulating members of all four G protein families. Proc. Natl Acad. Sci. U.S.A. 93, 116-120.
139. Li, D. Y., Varma, D. R., Chatterjee, T. K., Fernandez, H., Abran, D., and Chemtob, S. (1993). Fewer PGE2 and PGF2 alpha receptors in brain synaptosomes of newborn than of adult pigs. J. Pharmacol Exp. Ther. 267, 1292-1297.
140. Li, J., Liang, X., Wang, Q., Breyer, R. M., McCullough, L., and Andreasson, K. (2008). Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Neurosci. Lett. 438, 210-215.
141. Li, R. C., Saleem, S., Zhen, G., Cao, W., Zhuang, H., Lee, J., et al. (2009). Heme-hemopexin complex attenuates neuronal cell death and stroke damage.J. Cereb. Blood Flow Metab. 29, 953-964.
142. Li, X., Cudaback, E., Breyer, R. M., Montine, K. S., Keene, C. D., and Montine, T. J. (2012). Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor. FASEB J. 26, 3075-3083.
143. Liang, X., Wu, L., Hand, T., and Andreas-son, K. (2005). Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J. Neurochem. 92, 477-486.
144. Liang, Y., Woodward, D. F., Guzman, V M., Li, C., Scott, D. F., Wang, J. W., et al. (2008). Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br. J. Pharmacol. 154, 1079-1093.
145. Liu, D., Wu, L., Breyer, R., Mattson, M. P., and Andreasson, K. (2005). Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann. Neurol. 57, 758-761.
146. Lorenowicz, M. J., Fernandez-Borja, M., and Hordijk, P. L. (2007). cAMP signaling in leukocyte transendothe-lial migration. Arterioscler. Thromb. Vasc. Biol. 27, 1014-1022.
147. Lorenowicz, M. J., van Gils, J., De Boer, M., Hordijk, P. L., and Fernandez-Borja, M. (2006). Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. J. Leukoc. Biol. 80, 1542-1552.
148. Macdonald,R.L.,and Weir,B.K. (1991). A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22, 971-982.
149. Manawadu, D., Jeerakathil, T., Roy, A., Orwaard-Wong, K., and Butcher, K. (2010). Blood pressure management in acute intracerebral haemorrhage guidelines are poorly implemented in clinical practice. Clin. Neurol. Neurosurg. 112, 858-864.
150. Masada, T., Hua, Y., Xi, G., Yang, G. Y., Hoff, J. T., and Keep, R. F. (2001). Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J. Neurosurg. 95, 680-686.
151. Matsugi, T., Kageyama, M., Nishimura, K., Giles, H., and Shirasawa, E. (1995). Selective prostaglandin D2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats. Eur. J.Pharmacol. 275, 245-250.
152. Matsumura, K., Watanabe, Y., Imai-Matsumura, K., Connolly, M., Koyama, Y., and Onoe, H. (1992). Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res. 581, 292-298.
153. Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., et al. (2000). Prostaglandin D2 as a mediator of allergic asthma. Science 287, 2013-2017.
154. Mayne, M., Fotheringham, J., Yan, H. J., Power, C., Del Bigio, M. R., Peeling, J., et al. (2001a). Adenosine A2A receptor activation reduces proin-flammatory events and decreases cell death following intracerebral hemorrhage. Ann. Neurol. 49, 727-735.
155. Mayne, M., Ni, W., Yan, H. J., Xue, M., Johnston, J. B., Del Bigio, M. R., et al. (2001b). Antisense oligodeoxynu-cleotide inhibition of tumor necrosis factor-alpha expression is neuro-protective after intracerebral hemorrhage. Stroke 32, 240-248.
156. McCullough, L., Wu, L., Haughey, N., Liang, X., Hand, T., Wang, Q., et al. (2004). Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 24, 257-268.
157. Miggin, S. M., and Kinsella, B. T. (1998). Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms. Biochim. Biophys. Acta 1425, 543-559.
158. Miggin, S. M., Lawler, O. A., and Kinsella, B. T. (2003). Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation. J. Biol. Chem. 278, 6947-6958.
159. Mizoguchi, A., Eguchi, N., Kimura, K., Kiyohara, Y., Qu, W. M., Huang, Z. L., et al. (2001). Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U.S.A. 98, 11674-11679.
160. Mohri, I., Kadoyama, K., Kanekiyo, T., Sato, Y., Kagitani-Shimono, K., Saito,Y.,et al. (2007). Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. J. Neuropathol Exp. Neurol. 66, 469-480.
161. Moncada, S., Herman, A. G., Higgs, E. A., and Vane, J. R. (1977a). Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res 11, 323-344.
162. Moncada, S., Vane, J. R., and Whittle, B J. (1977b). Relative potency of prostacyclin, prostaglandin E1 and [2D] as inhibitors of platelet aggrega tion in several species [proceedings]. J. Physiol.(Lond.) 273, 2P-4P.
163. Monneret, G., Gravel, S., Diamond, M., Rokach, J., and Powell, W. S. (2001). Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98, 1942-1948.
164. Morgenweck, J., Abdel-Aleem, O. S., McNamara, K. C., Donahue, R. R., Badr, M. Z., and Taylor, B. K. (2010). Activation of peroxi-some proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharma-cology 58, 337-345.
165. Moxon-Emre, I., and Schlichter, L. C (2011). Neutrophil depletion reduces blood-brain barrier break down, axon injury, and inflam mation after intracerebral hemor rhage. J. Neuropathol. Exp. Neurol. 70, 218-235.
166. Muck,S.,Weber,A.A.,Meyer-Kirchrath, J., and Schror, K. (1998). The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization. Naunyn Schmiedebergs Arch. Pharmacol. 357, 10-16.
167. Murray, A. J., and Shewan, D. A. (2008). Epac mediates cyclic AMP-dependent axon growth, guidance and regeneration. Mol. Cell. Neu-rosci. 38, 578-588.
168. Nagata, K., Hirai, H., Tanaka, K., Ogawa, K., Aso, T., Sugamura, K., et al. (1999a). CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett. 459, 195-199.
169. Nagata, K., Tanaka, K., Ogawa, K., Kem-motsu, K., Imai, T., Yoshie, O., et al. (1999b). Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162, 1278-1286.
170. Nakamura, K., Kaneko, T., Yamashita, Y., Hasegawa, H., Katoh, H., and Negishi, M. (2000). Immuno-histochemical localization of prostaglandin EP3 receptor in the rat nervous system. J. Comp. Neurol. 421, 543-569.
171. Nakamura, Y., Nakamura, K., and Morrison, S. E (2009). Different populations of prostaglandin EP3 receptor-expressing preoptic neurons project to two fever-mediating sympathoex-citatory brain regions. Neuroscience 161, 614-620.
172. Namba, T., Oida, H., Sugimoto, Y., Kak-izuka, A., Negishi, M., Ichikawa, A., et al. (1994). cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla. J. Biol. Chem. 269, 9986-9992.
173. Namba, T., Sugimoto, Y., Hirata, M., Hayashi, Y., Honda, A., Watabe, A., et al. (1992). Mouse thrombox-ane A2 receptor: cDNA cloning, expression and northern blot analysis. Biochem. Biophys. Res. Commun. 184, 1197-1203.
174. Namiranian, K., Koehler, R. C., Sapirstein, A., and Doré, S. (2005). Stroke outcomes in mice lacking the genes for neuronal heme oxygenase-2 and nitric oxide synthase. Curr. Neurovasc. Res. 2, 23-27.
175. Narumiya, S. (2009). Prostanoids and inflammation: a new concept arising from receptor knockout mice. J. Mol. Med. (Berl.) 87, 1015-1022.
176. Narumiya, S., and Fitzgerald, G. A. (2001). Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108, 25-30.
177. Narumiya, S., Ogorochi, T., Nakao, K., and Hayaishi, O. (1982). Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 31, 2093-2103.
178. Narumiya, S., Sugimoto, Y., and Ushikubi, E (1999). Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79, 1193-1226.
179. Narumiya, S., and Toda, N. (1985). Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. Br. J. Pharmacol. 85, 367-375.
180. Narumiya, S., Ushikubi, F., Naka-jima, M., Hirata, M., and Okuma, M. (1991). Purification and characterization of the human platelet TXA2/PGH2 receptor. Adv. Prostaglandin Thromboxane Leukot. Res. 21A, 339-346.
181. Nishigaki, N., Negishi, M., and Ichikawa, A. (1996). Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol. Pharmacol. 50, 1031-1037.
182. Obal, E Jr., and Krueger, J. M. (2003). Biochemical regulation of non-rapid-eye-movement sleep. Front. Biosci. 8, d520-d550.
183. Offermanns, S., Hu, Y H., and Simon, M. I. (1996). Galpha12 and gal-pha13 are phosphorylated during platelet activation. J.Biol. Chem. 271, 26044-26048.
184. Ogorochi, T., Narumiya, S., Mizuno, N., Yamashita, K., Miyazaki, H., and Hayaishi, O. (1984). Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. J. Neu-rochem. 43, 71-82.
185. Oida, H., Hirata, M., Sugimoto, Y., Ushikubi, F., Ohishi, H., Mizuno, N., et al. (1997). Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain. FEBS Lett. 417, 53-56.
186. Oida, H., Namba, T., Sugimoto, Y., Ushikubi, F., Ohishi, H., Ichikawa, A., et al. (1995). In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br. J. Pharmacol. 116, 2828-2837.
187. Oliveira, M. S., Furian, A. F., Rambo, L. M., Ribeiro, L. R., Royes, L. F., Ferreira, J., et al. (2008). Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors. Neuroscience 152, 1110-1118.
188. Orie, N. N., and Clapp, L. H. (2011). Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors. Eur. J. Pharmacol. 654, 258-265.
189. Peeling, J., Yan, H. J., Chen, S. G., Campbell, M., and Del Bigio, M. R. (1998). Protective effects of free radical inhibitors in intracerebral hemorrhage in rat. Brain Res. 795, 63-70.
190. Penn, R. B., Pascual, R. M., Kim, Y. M., Mundell, S. J., Krymskaya, V. P., Panettieri, R. A. Jr., et al. (2001). Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J. Biol. Chem. 276, 32648-32656.
191. Pickard, J. D., Walker, V., Brandt, L., Zygmunt, S., and Smythe, J. (1994). Effect of intraventricular haemorrhage and rebleeding following sub-arachnoid haemorrhage on CSF eicosanoids. Acta Neurochir. (Wien) 129, 152-157.
192. Qian, Y M., Jones, R. L., Chan, K. M., Stock, A. I., and Ho, J. K. (1994). Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Br. J. Pharmacol. 113, 369-374.
193. Qing, W. G., Dong, Y Q., Ping, T. Q., Lai, L. G., Fang, L. D., Min, H. W., et al. (2009). Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. J. Neurosurg. 110, 462-468.
194. Raychowdhury, M. K., Yukawa, M., Collins, L. J., McGrail, S. H., Kent, K. C.,and Ware,J.A. (1994).Alternative splicing produces a divergent cyto-plasmic tail in the human endothe-lial thromboxane A2 receptor. J. Biol. Chem. 269, 19256-19261.
195. Regan, J. W., Bailey, T. J., Pepperl, D. J., Pierce, K. L., Bogardus, A. M., Donello, J. E., et al. (1994). Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46, 213-220.
196. Rehni, A. K., and Singh, T. G. (2012). Selenium induced anticonvulsant effect: a potential role of prostaglandin E(1) receptor activation linked mechanism. J. Trace Elem. Med. Biol. doi:10.1016/j.jtemb.2012.05.001
197. Richards, J. A., and Brueggemeier, R. W. (2003). Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J. Clin. Endocrinol. Metab. 88, 2810-2816.
198. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., et al. (2012). Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125, e2-220.
199. Rondaij, M. G., Sellink, E., Gijzen, K. A., Ten Klooster, J. P., Hordijk, P. L., van Mourik, J. A., et al. (2004). Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24, 1315-1320.
200. Saleem, S., Ahmad, A. S., Maruyama, T., Narumiya, S., and Doré, S. (2009a). PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia. Neurotox. Res. 15, 62-70.
201. Saleem, S., Kim, Y. T., Maruyama, T., Narumiya, S., and Doré, S. (2009b). Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia. J. Neuroimmunol. 208, 87-93.
202. Saleem, S., Shah, Z. A., Urade, Y., and Doré, S. (2009c). Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia. Neuroscience 160, 248-254.
203. Saleem, S., Li, R., Wei, G., and Doré, S. (2007a). Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J. Neurosci. Res. 85, 2433-2440.
204. Saleem, S., Li, R. C., Wei, G., and Doré, S. (2007b). Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J. Neurosci. Res. 85, 2433-2440.
205. Saleem, S., Zhuang, H., De Brum-Fernandes, A. J., Maruyama, T., Narumiya, S., and Doré, S. (2007c). PGD2 DP1 receptor protects brain from ischemia-reperfusion injury. Eur. J. Neurosci. 26, 73-78.
206. Saleem, S., Shah, Z. A., Maruyama, T., Narumiya, S., and Doré, S. (2010). Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia. Neuroscience 170, 317-323.
207. Saloheimo, P., Juvela, S., Riutta, A., Pyhtinen, J., and Hillbom, M. (2005). Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thromb. Res. 115, 367-373.
208. Sang, N., Zhang, J., Marcheselli, V., Bazan, N. G., and Chen, C. (2005). Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission viaapresynapticPGE2 EP2 receptor. J. Neurosci. 25, 9858-9870.
209. Sanzgiri, R. P., Araque, A., and Hay-don, P. G. (1999). Prostaglandin E(2) stimulates glutamate receptor-dependent astrocyte neuromodula-tion in cultured hippocampal cells. J.Neurobiol. 41, 221-229.
210. Sarrafzadeh, A., Haux, D., Sakowitz, O., Benndorf, G., Herzog, H., Kuech-ler, I., et al. (2003). Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 34, 1382-1388.
211. Satoh, T., Ishikawa, Y., Kataoka, Y., Cui, Y., Yanase, H., Kato, K., et al. (1999). CNS-specific prostacy-clin ligands as neuronal survival-promoting factors in the brain. Eur. J.Neurosci. 11, 3115-3124.
212. Sawyer, N., Cauchon, E., Chateauneuf, A., Cruz, R. P. G., Nicholson, D. W., Metters, K. M., et al. (2002). Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br. J. Pharmacol. 137, 1163-1172.
213. Schmid, A., Thierauch, K. H., Schleun-ing, W. D., and Dinter, H. (1995). Splice variants of the human EP3 receptor for prostaglandin E2. Eur. J. Biochem. 228, 23-30.
214. Schwartz-Bloom, R. D., Cook, T. A., and Yu, X. (1996). Inhibition of GABA-gated chloride channels in brain by the arachidonic acid metabolite, thromboxane A2. Neuropharmacol-ogy 35, 1347-1353.
215. Shenker, A., Goldsmith, P., Unson, C. G., and Spiegel, A. M. (1991). The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. J.Biol.Chem. 266, 9309-9313.
216. Shi, G. X., Rehmann, H., and Andres, D. A. (2006). A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation. Mol Cell. Biol. 26, 9136-9147.
217. Shi, J., Johansson, J., Woodling, N. S., Wang, Q., Montine, T. J., and Andreasson, K. (2010). The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J. Immunol. 184, 7207-7218.
218. Stapleton, P. P., Strong, V.E., Freeman, T. A., Winter, J., Yan, Z., and Daly, J. M. (2004). Gender affects macrophage cytokine and prostaglandin E2 production and PGE2 receptor expression after trauma. J. Surg. Res. 122, 1-7.
219. Sturzebecher, S., Nieuweboer, B., Matthes, S., and Schillinger, E. (1989). Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfil-tered platelets. Prog. Clin. Biol. Res. 301, 365-369.
220. Sugimoto, Y., Negishi, M., Hayashi, Y., Namba, T., Honda, A., Watabe, A., et al. (1993). Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins. J. Biol. Chem. 268, 2712-2718.
221. Sugimoto, Y., Shigemoto, R., Namba, T., Negishi, M., Mizuno, N., Naru-miya, S., et al. (1994). Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system. Neuroscience 62, 919-928.
222. Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., et al. (1997). Failure of parturition in mice lacking the prostaglandin F receptor. Science 277, 681-683.
223. Sumii, T., and Lo, E. H. (2002). Involvement of matrix metalloproteinase in thrombolysis-associated hemor-rhagic transformation after embolic focal ischemia in rats. Stroke 33, 831-836.
224. Suzuki, S., Yokoyama, U., Abe, T., Kiy-onari, H., Yamashita, N., Kato, Y., et al. (2010). Differential roles of Epac in regulating cell death in neuronal and myocardial cells. J. Biol. Chem. 285, 24248-24259.
225. Takamatsu, H., Tsukada, H., Watan-abe, Y., Cui, Y., Kataoka, Y., Hosoya, T., et al. (2002). Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia. Brain Res. 925, 176-182.
226. Takasugi, S., Ueda, S., and Matsumoto, K. (1985). Chronological changes in spontaneous intracerebral hematoma - an experimental and clinical study. Stroke 16, 651-658.
227. Takayama,K.,Yuhki,K.,Ono,K.,Fujino, T., Hara, A., Yamada, T., et al. (2005). Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia. Nat. Med. 11, 562-566.
228. Takechi, H., Matsumura, K., Watanabe, Y., Kato, K., Noyori, R., and Suzuki, M. (1996). A novel subtype of the prostacyclin receptor expressed in the central nervous system. J. Biol. Chem. 271, 5901-5906.
229. Takemiya, T., Maehara, M., Matsumura, K., Yasuda, S., Sugiura, H., and Yam-agata, K. (2006). Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neu-rosci. Res. 56, 103-110.
230. Takemiya, T., Matsumura, K., Sugiura, H., Maehara, M., Yasuda, S., Uematsu, S., et al. (2010). Endothe-lial microsomal prostaglandin E synthase-1 exacerbates neuronal loss induced by kainate. J. Neurosci. Res. 88, 381-390.
231. Takemiya, T., Matsumura, K., Sugiura, H., Yasuda, S., Uematsu, S., Akira, S., et al. (2011). Endothelial microsomal prostaglandin E synthase-1 facilitates neurotoxicity by elevating astrocytic Ca2+ levels. Neurochem. Int. 58, 489-496.
232. Tang, E. H., Libby, P., Vanhoutte, P. M., and Xu, A. (2012). Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J. Cardiovasc. Pharmacol. 59, 116-123.
233. Taniguchi, H., Anacker, C., Suarez-Mier, G. B., Wang, Q., and Andreasson, K. (2011a). Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy. Neurosci. Lett. 504, 185-190.
234. Taniguchi, H., Anacker, C., Suarez-Mier, G. B., Wang, Q., and Andreasson, K. (2011b). Function of prostaglandin E(2) EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy. Neurosci. Lett. 504, 185-190.
235. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Mano-lio, T., et al. (2006). Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113, e85-e151.
236. Toh, H., Ichikawa, A., and Narumiya, S. (1995). Molecular evolution of receptors for eicosanoids. FEBS Lett. 361, 17-21.
237. Urade, Y., and Hayaishi, O. (1999). Prostaglandin D2 and sleep regulation. Biochim. Biophys. Acta 1436, 606-615.
238. Ushikubi, F., Aiba, Y., Nakamura, K., Namba, T., Hirata, M., Mazda, O., et al. (1993). Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178, 1825-1830.
239. van Kooten, F., Ciabattoni, G., Koud-staal, P. J., Dippel, D. W., and Patrono, C. (1999a). Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. Stroke 30, 546-549.
240. van Kooten, F., Ciabattoni, G., Koud-staal, P. J., Grobbee, D. E., Kluft, C., and Patrono, C. (1999b). Increased thromboxane biosynthesis is associated with poststroke dementia. Stroke 30, 1542-1547.
241. Vane, J. R., and Botting, R. M. (1995). Pharmacodynamic profile of prostacyclin. Am. J. Cardiol. 75, 3A-10A.
242. Vasilache, A. M., Andersson, J., and Nils-berth, C. (2007). Expression of PGE2 EP3 receptor subtypes in the mouse preoptic region. Neurosci. Lett. 423, 179-183.
243. Wagner, K. R., Xi, G., Hua, Y., Klein-holz, M., De Courten-Myers, G. M., and Myers, R. E. (1998). Early metabolic alterations in edematous peri-hematomal brain regions following experimental intracerebral hemorrhage. J. Neurosurg. 88, 1058-1065.
244. Wagner,K. R.,Xi, G., Hua,Y.,Zuccarello, M., De Courten-Myers, G. M., Brod-erick, J. P., et al. (1999). Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J. Neurosurg. 90, 491-498.
245. Wang, H., Oestreich, E. A., Maekawa, N., Bullard, T. A., Vikstrom, K. L., Dirksen, R. T., et al. (2005). Phos-pholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. Circ. Res. 97, 1305-1313.
246. Wang, H. C., Lin, W. C., Lin, Y J., Rau, C. S., Lee, T. H., Chang, W. N., et al. (2011). The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage. Crit. Care 15, R284.
247. Wang, J., and Doré, S. (2007a). Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 130, 1643-1652.
248. Wang, J., and Doré, S. (2007b). Inflammation after intracerebral hemorrhage.J. Cereb. Blood FlowMetab. 27, 894-908.
249. Wang, J., and Doré, S. (2008). Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage. Neuroscience 155, 1133-1141.
250. Wang, J., Fields, J., and Doré, S. (2008). The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood. Brain Res. 1222, 214-221.
251. Wang, J., Zhuang, H., and Doré, S. (2006). Heme oxygenase 2 is neu-roprotective against intracerebral hemorrhage. Neurobiol. Dis. 22, 473-476.
252. Wasserman, J. K., Yang, H., and Schlichter, L. C. (2008). Glial responses, neuron death and lesion resolution after intracerebral hemorrhage in young vs. aged rats. Eur. I Neurosd. 28, 1316-1328.
253. Watabe, A., Sugimoto, Y., Honda, A., Irie, A., Namba, T., Negishi, M., et al. (1993). Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J. Biol. Chem. 268, 20175-20178.
254. Watanabe, Y., Matsumura, K., Takechi, H., Kato, K., Morii, H., Bjorkman, M., et al. (1999). A novel subtype of prostacyclin receptor in the central nervous system. J. Neurochem. 72, 2583-2592.
255. Watanabe, Y., Tokumoto, H., Yamashita, A., Narumiya, S., Mizuno, N., and Hayaishi, O. (1985). Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. Brain Res. 342, 110-116.
256. Wei, G., Kibler, K. K., Koehler, R. C., Maruyama, T., Narumiya, S., and Doré, S. (2008). Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse. Neuroscience 156, 1111-1117.
257. Weinberg, E., Zeldich, E., Weinreb, M. M., Moses, O., Nemcovsky, C., and Weinreb, M. (2009). Prostaglandin E2 inhibits the proliferation of human gingival fibroblasts via the EP2 receptor and Epac. J. Cell. Biochem. 108, 207-215.
258. Whittle, B. J., Moncada, S., Mul-lane, K., and Vane, J. R. (1983). Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. Prostaglandins 25, 205-223.
259. Willmore, L. J., and Triggs, W J. (1991). Iron-induced lipid peroxidation and brain injury responses. Int. J. Dev. Neurosci. 9, 175-180.
260. Wolfe, L. S., and Mamer, O. A. (1975). Measurement of prostaglandin F2alpha levels in human cere-brospinal fluid in normal and pathological conditions. Prostaglandins 9, 183-192.
261. Woodward, D. F., Jones, R. L., and Narumiya, S. (2011). International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63, 471-538.
262. Xi, G., Hua, Y., Bhasin, R. R., Ennis, S. R., Keep, R. F., and Hoff, J. T. (2001). Mechanisms of edema formation after intracerebral hemorrhage: effects of extravasated red blood cells on blood flow and blood-brain barrier integrity. Stroke 32, 2932-2938.
263. Xi, G., Hua, Y., Keep, R. F., Younger, J. G., and Hoff, J. T. (2002). Brain edema after intracerebral hemorrhage: the effects of systemic complement depletion. Acta Neurochir. Suppl. 81, 253-256.
264. Xue, M., and Del Bigio, M. R. (2000). Intracerebral injection of autolo-gous whole blood in rats: time course of inflammation and cell death. Neurosci. Lett. 283, 230-232.
265. Yalcin,M.,Cavun,S.,Yilmaz, M. S., Cen-giz, F., and Savci, V. (2005). Involvement of brain thromboxane A in hypotension induced by haemorrhage in rats. Clin. Exp. Pharmacol. Physiol. 32, 960-967.
266. Yang, H., Zhang, J., Breyer, R. M., and Chen, C. (2009). Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor. J. Neurochem. 108, 295-304.
267. Zeynalov, E., Shah, Z. A., Li, R. C., and Doré, S. (2009). Heme oxyge-nase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol. Dis. 35, 264-269.
268. Zhang, J., and Rivest, S. (1999). Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 11, 2651-2668.
269. Zhao, F., Song, S., Liu, W., Keep, R. E, Xi, G., and Hua, Y (2011). Red blood cell lysis and brain tissue-type transglutaminase upregulation in a hippocampal model of intracerebral hemorrhage. Acta Neurochir. Suppl. 111, 101-105.
270. Zhao, X., Sun, G., Zhang, J., Strong, R., Song, W., Gonzales, N., et al. (2007). Hematoma resolution as a target for intracerebral hemorrhage treatment: Role for peroxi-some proliferator-activated receptor gamma in microglia/macrophages. Ann.Neurol. 61, 352-362.
271. Zhou, P., Qian, L., Chou, T., and Iadecola, C. (2008). Neuroprotec-tion by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway. Neurobiol. Dis. 29, 543-551.
272. Zhu, P., Genc, A., Zhang, X., Zhang, J., Bazan, N. G., and Chen, C. (2005). Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors. J. Neurosci. Res. 81, 817-826.
273. Zonta, M., Sebelin, A., Gobbo, S., Fellin, T., Pozzan, T., and Carmignoto, G. (2003). Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes. J. Physiol. (Lond.) 553, 407-414.